You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!Submit Review
High affinity angiotensin-converting enzyme (ACE) ligand (Kd = 2.79 nM). Exhibits no significant effect on ACE enzymatic activity up to 500 nM concentration. Potentiates NMDA + D-serine-induced dopamine release from striatal slices in vitro and the striatum in vivo.
|Storage||Store at -20°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
|Solubility||Soluble to 2 mg/ml in water|
References are publications that support the biological activity of the product.
Neasta et al (2016) The novel nonapeptide acein targets angiotensin converting enzyme in the brain and induces DA release. Br.J.Pharmacol. 173 1314 PMID: 27027724
If you know of a relevant reference for Acein, please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: Acein, Acein supplier, High, affinity, angiotensin, converting, enzymes, ACE, ligands, Angiotensin-Converting, Enzyme, 6006, Tocris Bioscience
Citations for Acein
Citations are publications that use Tocris products.
Currently there are no citations for Acein. Do you know of a great paper that uses Acein from Tocris? Please let us know.
Reviews for Acein
There are currently no reviews for this product. Be the first to review Acein and earn rewards!
Have you used Acein?
Submit a review and receive an Amazon gift card.
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.